NGR-hTNF, a vascular targeting agent (VTA), in previously treated patients with malignant pleural mesothelioma (MPM): a phase II study

被引：0

作者：

Gregorc, V. ^{[1
]}

Ceresoli, G. L. ^{[2
]}

Zucali, P. A. ^{[2
]}

De Braud, F. G. ^{[3
]}

Bajetta, E. ^{[4
]}

Santoro, A. ^{[2
]}

Vigano, M. G. ^{[1
]}

Cappio, F. Caligaris ^{[1
]}

Lambiase, A. ^{[5
]}

Bordignon, C. ^{[5
]}

机构：

[1] Ist Sci San Raffaele, Dept Oncol, Milan, Italy

[2] Ist Clin Humanitas, Dept Oncol, Milan, Italy

[3] Ist Europeo Oncol, Clin Pharmacol & New Drugs Unit, Milan, Italy

[4] IRCCS Fdn, Ist Nazl Tumori, Dept Oncol, Milan, Italy

[5] MolMed, Clin Dev, Milan, Italy

来源：

EJC SUPPLEMENTS | 2009年 / 7卷 / 02期

关键词：

D O I：

10.1016/S1359-6349(09)71724-0

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：509 / 509

页数：1

共 50 条

[41] Phase II study of pemetrexed in combination with carboplatin in patients with malignant pleural mesothelioma (MPM) [J].

Castagneto, B. ;

Botta, M. ;

Aitini, E. ;

Spigno, F. ;

Degiovanni, D. ;

Alabiso, O. ;

Serra, M. ;

Muzio, A. ;

Carbone, R. ;

Buosi, R. ;

Galbusera, V. ;

Piccolini, E. ;

Giaretto, L. ;

Rebella, L. ;

Mencoboni, M. .

ANNALS OF ONCOLOGY, 2008, 19 (02) :370-373

[42] A phase II single-arm study of CRS-207 with pembrolizumab (pembro) in previously treated malignant pleural mesothelioma (MPM). [J].

Alley, Evan W. ;

Tanvetyanon, Tawee ;

Jahan, Thierry Marie ;

Gandhi, Leena ;

Peikert, Tobias ;

Stevenson, James ;

Schlienger, Katia ;

Liu, Weiqun ;

Nair, Nitya ;

Honarmand, Somayeh ;

Kindler, Hedy L. .

JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (08)

[43] Defining the optimal biological dose of NGR-hTNF, a selective vascular targeting agent, in advanced solid tumours [J].

Gregorc, Vanesa ;

Citterio, Giovanni ;

Vitali, Giordano ;

Spreafico, Anna ;

Scifo, Paola ;

Borri, Anna ;

Donadoni, Giovanni ;

Rossoni, Gilda ;

Corti, Angelo ;

Caligaris-Cappio, Federico ;

Del Maschio, Alessandro ;

Esposito, Antonio ;

De Cobelli, Francesco ;

Dell'Acqua, Flavio ;

Troysi, Antonella ;

Bruzzi, Paolo ;

Lambiase, Antonio ;

Bordignon, Claudio .

EUROPEAN JOURNAL OF CANCER, 2010, 46 (01) :198-206

[44] Phase II Study of NGR-hTNF Plus Doxorubicin in Relapsed Ovarian Cancer (OC) [J].

Lorusso, D. ;

Scambia, G. ;

Amadio, G. ;

Trivellizzi, N. ;

Pietragalla, A. ;

De Vincenzo, R. ;

Salutari, V. ;

Di Stefano, M. ;

Lambiase, A. ;

Bordignon, C. .

EUROPEAN JOURNAL OF CANCER, 2011, 47 :S536-S536

[45] Mutational Profile of Malignant Pleural Mesothelioma (MPM) in the Phase II RAMES Study [J].

Pagano, Maria ;

Ceresoli, Luca Giovanni ;

Zucali, Paolo Andrea ;

Pasello, Giulia ;

Garassino, Marina ;

Grosso, Federica ;

Tiseo, Marcello ;

Soto Parra, Hector ;

Zanelli, Francesca ;

Cappuzzo, Federico ;

Grossi, Francesco ;

De Marinis, Filippo ;

Pedrazzoli, Paolo ;

Gnoni, Roberta ;

Bonelli, Candida ;

Torricelli, Federica ;

Ciarrocchi, Alessia ;

Normanno, Nicola ;

Pinto, Carmine .

CANCERS, 2020, 12 (10) :1-12

[46] Mutational profile of malignant pleural mesothelioma (MPM) in the phase II RAMES study [J].

Pagano, M. ;

Gnoni, R. ;

Bonelli, C. ;

Zanelli, F. ;

Garassino, M. C. ;

Ceresoli, G. L. ;

Pasello, G. ;

Tiseo, M. ;

Parra, H. J. Soto ;

Grosso, F. ;

Zucali, P. A. ;

Larocca, M. ;

Torricelli, F. ;

Ciarrocchi, A. ;

Pinto, C. .

ANNALS OF ONCOLOGY, 2019, 30

[47] Premature phase II study of amrubicin as palliative chemotherapy for previously treated malignant pleural mesothelioma [J].

Watanabe, Kageaki ;

Okuma, Yusuke ;

Kawai, Shoko ;

Nagamata, Makoto ;

Hosomi, Yukio .

THORACIC CANCER, 2021, 12 (11) :1668-1672

[48] Phase II study of NGR-hTNF plus doxorubicin in relapsed ovarian cancer (OC). [J].

Scambia, G. ;

Lorusso, D. ;

Amadio, G. ;

Trivellizzi, N. ;

Pietragalla, A. ;

De Vincenzo, R. ;

Salutari, V. ;

Di Stefano, M. ;

Mangili, G. ;

Montoli, S. ;

Citterio, G. ;

Lambiase, A. ;

Bordignon, C. .

JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)

[49] A phase II trial of nintedanib in recurrent malignant pleural mesothelioma (MPM). [J].

Wozniak, Antoinette J. ;

Schneider, Bryan J. ;

Kalemkerian, Gregory Peter ;

Daly, Robert Michael ;

Chen, Wei ;

Ventimiglia, Jaclyn ;

Nagasaka, Misako ;

Zauderer, Marjorie Glass .

JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)

[50] Single-Agent Pembrolizumab for Patients with Malignant Pleural Mesothelioma (MPM) [J].

Alley, Evan W. ;

Schellens, Jan H. M. ;

Santoro, Armando ;

Beckey, Kim ;

Yuan, Shuai Sammy ;

Cheng, Jonathan ;

Piperdi, Bilal ;

Molife, L. Rhoda .

JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) :S195-S195

← 1 2 3 4 5 →